Induction of donor-specific tolerance in sublethally irradiated recipients by gene therapy

Molecular Therapy

Volumn 12, Issue 2, 2005, Pages 353-359

  Forman, Daron ^a   Tian, Chaorui ^a   Iacomini, John ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Gene therapy; Tolerance; Transplantation

Indexed keywords

CD4 ANTIGEN; CD40 LIGAND MONOCLONAL ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW CELL; CELL LINEAGE; CONTROLLED STUDY; DONOR; FEMALE; GENE THERAPY; GENETIC TRANSDUCTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HOST; ISOGRAFT; MOUSE; NONHUMAN; NONMYELOABLATIVE CONDITIONING; PROTEIN EXPRESSION; RADIATION CHIMERA; RADIATION DOSE; RECIPIENT; RETROVIRUS; SKIN GRAFT; SKIN TRANSPLANTATION; T LYMPHOCYTE; TRANSPLANTATION TOLERANCE; VESICULAR STOMATITIS VIRUS; WHOLE BODY RADIATION;

ANIMALS; ANTIBODIES, MONOCLONAL; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CD40 LIGAND; GENE THERAPY; GRAFT ENHANCEMENT, IMMUNOLOGIC; GRAFT SURVIVAL; HISTOCOMPATIBILITY; IMMUNE TOLERANCE; LYMPHOCYTE DEPLETION; MICE; RADIATION CHIMERA; T-LYMPHOCYTES; TRANSDUCTION, GENETIC; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 22644432853     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2005.03.035     Document Type: Article

References (40)

1. J. Dantal et al. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: Randomised comparison of two cyclosporin regimens Lancet 351 1998 623-628
2. C.G. Newstead Assessment of risk of cancer after renal transplantation Lancet 351 1998 610-611
3. M.S. Orloff et al. Prevention of chronic rejection and graft arteriosclerosis by tolerance induction Transplantation 59 1995 282-288
4. S. Slavin S. Strober Z. Fuks and H.S. Kaplan Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: Long-term survival of allogeneic bone marrow and skin grafts J. Exp. Med. 146 1977 34-48
5. S. Slavin Z. Fuks H.S. Kaplan and S. Strober Transplantation of allogeneic bone marrow without graft-versus-host disease using total lymphoid irradiation J. Exp. Med. 147 1978 963-972
6. R. Parkman and K.I. Weinberg Immunological reconstitution following bone marrow transplantation Immunol. Rev. 157 1997 73-78
7. M.A. Williams et al. Primary and secondary immunocompetence in mixed allogeneic chimeras J. Immunol. 170 2003 2382-2389
8. T. Sablinski et al. Pig to monkey bone marrow and kidney xenotransplantation Surgery 121 1997 381-391
9. M. Tanaka et al. Xenotransplantation from pig to cynomolgus monkey: The potential for overcoming xenograft rejection through induction of chimerism Transplant. Proc. 26 1994 1326-1327
10. J. Bagley and J. Iacomini Gene therapy progress and prospects: Gene therapy in organ transplantation Gene Ther. 10 2003 605-611
11. J. Bagley J.L. Bracy C. Tian E.S. Kang and J. Iacomini Establishing immunological tolerance through the induction of molecular chimerism Front. Biosci. 7 2002 d1331-d1337
12. J. Bagley C. Tian D.H. Sachs and J. Iacomini Induction of T-cell tolerance to an MHC class I alloantigen by gene therapy Blood 99 2002 4394-4399
13. J.L. Bracy C.M. Chase P.S. Russell S. Mauiyyedi R.B. Colvin and J. Iacomini Induction of molecular chimerism by gene therapy prevents antibody-mediated heart transplant rejection Gene Ther. 8 2001 1738-1744
14. J.L. Bracy and J. Iacomini Induction of B-cell tolerance by retroviral gene therapy Blood 96 2000 3008-3015
15. E.S. Kang and J. Iacomini Induction of central deletional T cell tolerance by gene therapy J. Immunol. 169 2002 1930-1935
16. C. Tian J. Bagley N. Cretin N. Seth K.W. Wucherpfennig and J. Iacomini Prevention of type 1 diabetes by gene therapy J. Clin. Invest. 114 2004 969-978
17. C. Tian J. Bagley and J. Iacomini Expression of antigen on mature lymphocytes is required to induce T cell tolerance by gene therapy J. Immunol. 169 2002 3771-3776
18. E. Seung et al. Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: Absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD/Lt mice Blood 95 2000 2175-2182
19. J. Bagley T. Sawada Y. Wu and J. Iacomini A critical role for interleukin 4 in activating alloreactive CD4 T cells Nat. Immunol. 1 2000 257-261
20. J. Storek et al. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease Blood 90 1997 4705-4709
21. S.J. Knechtle Knowledge about transplantation tolerance gained in primates Curr. Opin. Immunol. 12 2000 552-556
22. T.P. Baglin Veno-occlusive disease of the liver complicating bone marrow transplantation Bone Marrow Transplant. 13 1994 1-4
23. J.R. Wingard Opportunistic infections after blood and marrow transplantation Transplant. Infect. Dis. 1 1999 3-20
24. T.R. Spitzer Nonmyeloablative allogeneic stem cell transplant strategies and the role of mixed chimerism Oncologist 5 2000 215-223
25. T.H. Hansen D.H. Sachs The major histocompatibility complex in: W.E. Paul (Eds.) Fundamental Immunology 1989 Raven Press New York 445-487
26. J. Klein Natural History of the Major Histocompatibility Complex 1986 Wiley & Sons, Inc. New York
27. D. Forman et al. Viral abrogation of stem cell transplantation tolerance causes graft rejection and host death by different mechanisms J. Immunol. 168 2002 6047-6056
28. S.A. Quezada L.Z. Jarvinen E.F. Lind and R.J. Noelle CD40/CD154 interactions at the interface of tolerance and immunity Annu. Rev. Immunol. 22 2004 307-328
29. N.J. Monk et al. Fc-dependent depletion of activated T cells occurs through CD40L-specific antibody rather than costimulation blockade Nat. Med. 9 2003 1275-1280
30. D.W. Emery et al. Expression of an allogeneic MHC DRB transgene, through retroviral transduction of bone marrow, induces specific reduction of alloreactivity Transplantation 64 1997 1414-1423
31. J.W. Fry P.J. Morris and K.J. Wood Adenoviral transfer of a single donor-specific MHC class I gene to recipient bone marrow cells can induce specific immunological unresponsiveness in vivo Gene Ther. 9 2002 220-226
32. D.A. Heim et al. Introduction of a xenogeneic gene via hematopoietic stem cells leads to specific tolerance in a rhesus monkey model Mol. Ther. 1 2000 533-544
33. F.L. Ierino et al. Transfer of swine major histocompatibility complex class II genes into autologous bone marrow cells of baboons for the induction of tolerance across xenogeneic barriers Transplantation 67 1999 1119-1128
34. I.K. Schumacher et al. Use of gene therapy to suppress the antigen-specific immune responses in mice to an HLA antigen Transplantation 62 1996 831-836
35. K.C. Sonntag et al. Tolerance to solid organ transplants through transfer of MHC class II genes J. Clin. Invest. 107 2001 65-71
36. W. Wong J. Fry K. Hyde S. Stranford P.J. Morris and K.J. Wood Haematopoietic stem cells transduced with a single donor class I major histocompatibility complex gene can induce operational tolerance to fully allogeneic cardiac allografts Transplant. Proc. 31 1999 886
37. A. Bushell T.C. Pearson P.J. Morris and K.J. Wood Donor-recipient microchimerism is not required for tolerance induction following recipient pretreatment with donor-specific transfusion and anti-CD4 antibody: Evidence of a clear role for short-term antigen persistence Transplantation 59 1995 1367-1371
38. K. Hamano M.A. Rawsthorne A.R. Bushell P.J. Morris and K.J. Wood Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for maintenance of tolerance to alloantigen in vivo in anti-CD4 treated recipients Transplantation 62 1996 856-860
39. R.J. Noelle M. Roy D.M. Shepherd I. Stamenkovic J.A. Ledbetter and A. Aruffo A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells Proc. Natl. Acad. Sci. USA 89 1992 6550-6554
40. T. Sawada Y. Wu D.H. Sachs and J. Iacomini CD4+ T cells are able to reject class I disparate allografts Transplantation 64 1997 335-340